Merck
  • Home
  • Search Results
  • Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors.

Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors.

Pain (2014-09-25)
Eric Dubuis, Victoria Thompson, Maria Isabella Leite, Franz Blaes, Christian Maihöfner, David Greensmith, Angela Vincent, Nicolas Shenker, Anoop Kuttikat, Martin Leuwer, Andreas Goebel
ABSTRACT

Complex regional pain syndrome (CRPS) is a limb-confined posttraumatic pain syndrome with sympathetic features. The cause is unknown, but the results of a randomized crossover trial on low-dose intravenous immunoglobulins (IVIG) treatment point to a possible autoimmune mechanism. We tested purified serum immunoglobulin G (IgG) from patients with longstanding CRPS for evidence of antibodies interacting with autonomic receptors on adult primary cardiomyocytes, comparing with control IgG from healthy and diseased controls, and related the results to the clinical response to treatment with low-dose IVIG. We simultaneously recorded both single-cell contractions and intracellular calcium handling in an electrical field. Ten of 18 CRPS preparations and only 1/57 control preparations (P<0.0001) increased the sensitivity of the myocytes to the electric field, and this effect was abrogated by preincubation with α-1a receptor blockers. By contrast, effects on baseline calcium were blocked by preincubation with atropine. Interestingly, serum-IgG preparations from all 4 CRPS patients who had responded to low-dose IVIG with meaningful pain relief were effective in these assays, although 4/8 of the nonresponders were also active. To see if there were antibodies to the α-1a receptor, CRPS-IgG was applied to α-1a receptor-transfected rat-1 fibroblast cells. The CRPS serum IgG induced calcium flux, and fluorescence-activated cell sorting showed that there was serum IgG binding to the cells. The results suggest that patients with longstanding CRPS have serum antibodies to α-1a receptors, and that measurement of these antibodies may be useful in the diagnosis and management of the patients.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
蔗糖, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
蔗糖, ≥99.5% (GC)
Sigma-Aldrich
蔗糖, BioXtra, ≥99.5% (GC)
Sigma-Aldrich
蔗糖, BioUltra, for molecular biology, ≥99.5% (HPLC)
Supelco
蔗糖, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
蔗糖, puriss., meets analytical specification of Ph. Eur., BP, NF
USP
蔗糖, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
蔗糖, ACS reagent
Sigma-Aldrich
蔗糖, ≥99.5%
Sigma-Aldrich
蔗糖, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99.5% (GC)
Millipore
蔗糖, ACS reagent, suitable for microbiology, ≥99.0%
Sigma-Aldrich
钙, granular, 99%
Sigma-Aldrich
蔗糖, Grade II, suitable for plant cell culture
Sigma-Aldrich
阿托品, ≥99% (TLC), powder
Sigma-Aldrich
蔗糖, meets USP testing specifications
Supelco
蔗糖, analytical standard
Sigma-Aldrich
蔗糖, Grade I, suitable for plant cell culture
蔗糖, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
钙, dendritic pieces, purified by distillation, 99.99% trace metals basis
Sigma-Aldrich
钙, pieces, <1 cm, 99%
Sigma-Aldrich
钙, turnings, 99% trace metals basis
Supelco
蔗糖, analytical standard, for enzymatic assay kit SCA20
阿托品, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
钙, dendritic pieces, purified by distillation, 99.9% trace metals basis
峰鉴别用阿托品, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
钙, dendritic pieces, purified by distillation, 99.5% trace metals basis
Supelco
阿托品, analytical standard
Sigma-Aldrich
阿托品, meets USP testing specifications